IKNA
Price
$1.43
Change
+$0.03 (+2.14%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
JAZZ
Price
$108.99
Change
-$1.50 (-1.36%)
Updated
May 17, 6:59 PM EST
79 days until earnings call
Ad is loading...

IKNA vs JAZZ

Header iconIKNA vs JAZZ Comparison
Open Charts IKNA vs JAZZBanner chart's image
Ikena Oncology
Price$1.43
Change+$0.03 (+2.14%)
Volume$103.81K
CapitalizationN/A
Jazz Pharmaceuticals
Price$108.99
Change-$1.50 (-1.36%)
Volume$302.4K
CapitalizationN/A
View a ticker or compare two or three
IKNA vs JAZZ Comparison Chart

Loading...

IKNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
JAZZDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IKNA vs. JAZZ commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKNA is a StrongBuy and JAZZ is a Sell.

COMPARISON
Comparison
May 19, 2024
Stock price -- (IKNA: $1.43 vs. JAZZ: $108.99)
Brand notoriety: IKNA and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKNA: 68% vs. JAZZ: 88%
Market capitalization -- IKNA: $69.01M vs. JAZZ: $6.87B
IKNA [@Biotechnology] is valued at $69.01M. JAZZ’s [@Biotechnology] market capitalization is $6.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKNA’s FA Score shows that 2 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • IKNA’s FA Score: 2 green, 3 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, IKNA is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKNA’s TA Score shows that 5 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • IKNA’s TA Score: 5 bullish, 3 bearish.
  • JAZZ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IKNA is a better buy in the short-term than JAZZ.

Price Growth

IKNA (@Biotechnology) experienced а +10.85% price change this week, while JAZZ (@Biotechnology) price change was -0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

IKNA is expected to report earnings on Aug 08, 2024.

JAZZ is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IKNA with price predictions.
OPEN
A.I.dvisor published
a Summary for JAZZ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JAZZ($6.87B) has a higher market cap than IKNA($69M). JAZZ YTD gains are higher at: -11.390 vs. IKNA (-27.411).
IKNAJAZZIKNA / JAZZ
Capitalization69M6.87B1%
EBITDAN/AN/A-
Gain YTD-27.411-11.390241%
P/E RatioN/A22.57-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
66
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKNAJAZZ
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
62%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
69%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 21 days ago
63%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 5 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
57%
View a ticker or compare two or three
Ad is loading...
IKNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
JAZZDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLOK33.010.47
+1.44%
Amplify Transformational Data Shrg ETF
XCCC37.870.03
+0.08%
BondBloxx CCC Rated USD HY Corp Bd ETF
PULS49.650.01
+0.02%
PGIM Ultra Short Bond ETF
ETHO57.53-0.20
-0.34%
Amplify Etho Climate Leadership U.S. ETF
BBC27.26-0.55
-1.98%
Virtus LifeSci Biotech Clinical Trls ETF

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ATRA. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
+2.14%
ATRA - IKNA
71%
Closely correlated
+1.06%
AMLX - IKNA
54%
Loosely correlated
N/A
JAZZ - IKNA
41%
Loosely correlated
-1.36%
VNDA - IKNA
40%
Loosely correlated
-1.79%
FOLD - IKNA
37%
Loosely correlated
+0.74%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with AMLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
-1.36%
AMLX - JAZZ
43%
Loosely correlated
N/A
INCY - JAZZ
41%
Loosely correlated
+0.42%
SAGE - JAZZ
41%
Loosely correlated
-2.58%
IKNA - JAZZ
41%
Loosely correlated
+2.14%
INSM - JAZZ
39%
Loosely correlated
-1.31%
More